vs

Side-by-side financial comparison of CervoMed Inc. (CRVO) and TOP Financial Group Ltd (TOP). Click either name above to swap in a different company.

TOP Financial Group Ltd is the larger business by last-quarter revenue ($2.9M vs $1.8M, roughly 1.6× CervoMed Inc.). TOP Financial Group Ltd runs the higher net margin — 6.6% vs -356.1%, a 362.7% gap on every dollar of revenue.

CervoMed Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for neurodegenerative conditions such as Alzheimer’s disease and other forms of dementia. It operates in the global biopharmaceutical market, with core R&D segments dedicated to addressing unmet medical needs for patients with progressive brain disorders.

Sun Life Financial Inc. is a Canadian financial services company headquartered in Toronto, Ontario. Founded in 1865, it operates internationally in life insurance, wealth management, and asset management. As of 2024, the company manages over CAD$1.3 trillion in assets and serves clients in Canada, the United States, Asia, and other markets.

CRVO vs TOP — Head-to-Head

Bigger by revenue
TOP
TOP
1.6× larger
TOP
$2.9M
$1.8M
CRVO
Higher net margin
TOP
TOP
362.7% more per $
TOP
6.6%
-356.1%
CRVO

Income Statement — Q2 FY2025 vs Q2 FY2026

Metric
CRVO
CRVO
TOP
TOP
Revenue
$1.8M
$2.9M
Net Profit
$-6.3M
$190.5K
Gross Margin
Operating Margin
-376.4%
Net Margin
-356.1%
6.6%
Revenue YoY
-46.6%
Net Profit YoY
-170.1%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRVO
CRVO
TOP
TOP
Q3 25
$2.9M
Q2 25
$1.8M
Q1 25
$1.9M
Q4 24
$2.2M
Q3 24
$1.9M
Q2 24
$3.3M
Q1 24
$2.3M
Q4 23
$2.5M
Net Profit
CRVO
CRVO
TOP
TOP
Q3 25
$190.5K
Q2 25
$-6.3M
Q1 25
$-4.9M
Q4 24
$-6.7M
Q3 24
$-4.8M
Q2 24
$-2.3M
Q1 24
$-2.5M
Q4 23
$-2.4M
Operating Margin
CRVO
CRVO
TOP
TOP
Q3 25
Q2 25
-376.4%
Q1 25
-276.6%
Q4 24
-334.9%
Q3 24
-278.2%
Q2 24
-91.1%
Q1 24
-110.6%
Q4 23
-99.6%
Net Margin
CRVO
CRVO
TOP
TOP
Q3 25
6.6%
Q2 25
-356.1%
Q1 25
-255.2%
Q4 24
-310.2%
Q3 24
-245.1%
Q2 24
-70.4%
Q1 24
-107.1%
Q4 23
-94.9%
EPS (diluted)
CRVO
CRVO
TOP
TOP
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-0.55
Q2 24
Q1 24
Q4 23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRVO
CRVO
TOP
TOP
Cash + ST InvestmentsLiquidity on hand
$33.5M
$14.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$33.4M
$35.0M
Total Assets
$38.1M
$64.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRVO
CRVO
TOP
TOP
Q3 25
$14.8M
Q2 25
$33.5M
Q1 25
$35.2M
Q4 24
$38.9M
Q3 24
$46.7M
Q2 24
$45.1M
Q1 24
$6.4M
Q4 23
$7.8M
Stockholders' Equity
CRVO
CRVO
TOP
TOP
Q3 25
$35.0M
Q2 25
$33.4M
Q1 25
$34.6M
Q4 24
$39.2M
Q3 24
$45.6M
Q2 24
$50.0M
Q1 24
$5.3M
Q4 23
$7.4M
Total Assets
CRVO
CRVO
TOP
TOP
Q3 25
$64.1M
Q2 25
$38.1M
Q1 25
$38.6M
Q4 24
$43.1M
Q3 24
$48.9M
Q2 24
$53.2M
Q1 24
$8.0M
Q4 23
$10.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRVO
CRVO
TOP
TOP
Operating Cash FlowLast quarter
$-6.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRVO
CRVO
TOP
TOP
Q3 25
Q2 25
$-6.5M
Q1 25
$-3.9M
Q4 24
$-8.1M
Q3 24
$-4.9M
Q2 24
$-2.2M
Q1 24
$-1.4M
Q4 23
$-2.5M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons